Works matching IS 09395555 AND DT 2022 AND VI 101 AND IP 1
Results: 32
Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 1, doi. 10.1007/s00277-021-04690-x
- By:
- Publication type:
- Article
Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 99, doi. 10.1007/s00277-021-04675-w
- By:
- Publication type:
- Article
Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 147, doi. 10.1007/s00277-021-04687-6
- By:
- Publication type:
- Article
Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 139, doi. 10.1007/s00277-021-04683-w
- By:
- Publication type:
- Article
Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 131, doi. 10.1007/s00277-021-04682-x
- By:
- Publication type:
- Article
Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 191, doi. 10.1007/s00277-021-04681-y
- By:
- Publication type:
- Article
Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 177, doi. 10.1007/s00277-021-04676-9
- By:
- Publication type:
- Article
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 59, doi. 10.1007/s00277-021-04685-8
- By:
- Publication type:
- Article
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 119, doi. 10.1007/s00277-021-04674-x
- By:
- Publication type:
- Article
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 91, doi. 10.1007/s00277-021-04671-0
- By:
- Publication type:
- Article
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 109, doi. 10.1007/s00277-021-04670-1
- By:
- Publication type:
- Article
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 21, doi. 10.1007/s00277-021-04668-9
- By:
- Publication type:
- Article
Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 35, doi. 10.1007/s00277-021-04667-w
- By:
- Publication type:
- Article
Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 11, doi. 10.1007/s00277-021-04637-2
- By:
- Publication type:
- Article
miRNA profile and disease severity in patients with sickle cell anemia.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 27, doi. 10.1007/s00277-021-04665-y
- By:
- Publication type:
- Article
Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 81, doi. 10.1007/s00277-021-04663-0
- By:
- Publication type:
- Article
Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 155, doi. 10.1007/s00277-021-04658-x
- By:
- Publication type:
- Article
Prevalence of and risk factors for obstructive sleep apnea in children with sickle cell: a multicentric cross sectional study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 43, doi. 10.1007/s00277-021-04646-1
- By:
- Publication type:
- Article
Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 69, doi. 10.1007/s00277-021-04644-3
- By:
- Publication type:
- Article
Total body irradiation-containing conditioning regimens without antithymocyte globulin in adults with aplastic anemia undergoing umbilical cord blood transplantation.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 165, doi. 10.1007/s00277-021-04664-z
- By:
- Publication type:
- Article
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies.
- Published in:
- 2022
- By:
- Publication type:
- Letter
The first case of a collision tumor of gastrointestinal stromal tumor and intravascular large B cell lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia.
- Published in:
- 2022
- By:
- Publication type:
- Letter
CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Dose-adjusted high-dose chemotherapy with autologous stem cell transplantation for elderly (≥ 70 years old) lymphoma patients.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study.
- Published in:
- 2022
- By:
- Publication type:
- Letter